Treatment of sepsis with tafi

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 38/48 (2006.01)

Patent

CA 2462396

A method for inhibiting and for reversing the dysfunctional response of vascular endothelial cells to an inflammatory stimulus in a subject in need of such therapy has been developed in which an effective amount of a pharmaceutical composition comprising thrombin-activatable fibrinolysis inhibitor (TAFI) combined with a pharmaceutically acceptable carrier and optionally other treatments is administered to the subject.

L'invention concerne une méthode permettant d'inhiber et d'inverser la réponse dysfonctionnelle des cellules endothéliales vasculaires à un stimulus inflammatoire chez un sujet nécessitant un tel traitement. Dans cette méthode, on administre au sujet une quantité efficace d'une composition pharmaceutique comprenant un inhibiteur de la fibrinolyse activable par la thrombine (TAFI) combiné à un excipient acceptable sur le plan pharmaceutique et éventuellement à d'autres traitements.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of sepsis with tafi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of sepsis with tafi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sepsis with tafi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1486697

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.